AU Stock MarketDetailed Quotes
TYP Tryptamine Therapeutics Ltd
- 0.045
- 0.0000.00%
20min DelayMarket Closed Nov 22 15:58 AET
57.44MMarket Cap-494P/E (Static)
0.048High0.045Low1.85MVolume0.046Open0.045Pre Close85.33KTurnover0.05752wk High0.23%Turnover Ratio1.28BShares0.01752wk Low-0.038EPS TTM36.63MFloat Cap0.057Historical HighLossP/E (Static)814.01MShs Float0.017Historical Low-0.091EPS LYR6.67%Amplitude--Dividend TTM11.25P/B1Lot Size--Div YieldTTM
Tryptamine Therapeutics Ltd Key Stats
Quarterly+Annual
YOY
| (FY)Jun 30, 2023 | (FY)Jun 30, 2022 | (FY)Jun 30, 2021 | (FY)Jun 30, 2020 | (FY)Jun 30, 2019 | |
|---|---|---|---|---|---|
| Operating cash flow (direct method) | |||||
| Cash income from operating activities | 17.06%4.75M | 3,542.65%4.06M | -79.89%111.51K | 554.58K | |
| Revenue from customers | 524.00%618.57K | --99.13K | ---- | ---- | ---- |
| Income from government grants | 45.22%62.9K | --43.31K | ---- | ---- | ---- |
| Other cash income from operating activities | 3.93%4.07M | 3,414.91%3.92M | -79.89%111.51K | --554.58K | ---- |
| Cash paid | 31.65%-8.61M | -58.48%-12.59M | -8.68%-7.95M | -230.36%-7.31M | -2.21M |
| Payments to suppliers for goods and services | 31.65%-8.61M | -23.25%-12.59M | -39.74%-10.22M | -230.36%-7.31M | ---2.21M |
| Other cash payments from operating activities | ---- | ---- | --2.27M | ---- | ---- |
| Direct interest received | 78.27%6.99K | -36.22%3.92K | -89.85%6.15K | 110.43%60.58K | --28.79K |
| Operating cash flow | 54.90%-3.85M | -8.93%-8.53M | -16.90%-7.83M | -206.55%-6.7M | ---2.18M |
| Investing cash flow | |||||
| Cash flow from continuing investing activities | 77.60%-276.64K | 31.34%-1.24M | -89.44%-1.8M | -10.59%-949.59K | -858.65K |
| Net PPE purchase and sale | 75.41%-276.64K | 30.77%-1.13M | -157.26%-1.63M | -18.39%-631.8K | ---533.65K |
| Net intangibles purchas and sale | ---- | ---- | ---- | ---- | ---325K |
| Net investment purchase and sale | ---- | ---- | 32.12%-188.57K | ---277.79K | ---- |
| Net other investing changes | ---- | -832.99%-109.95K | 137.50%15K | ---40K | ---- |
| Cash from discontinued investing activities | |||||
| Investing cash flow | 77.60%-276.64K | 31.34%-1.24M | -89.44%-1.8M | -10.59%-949.59K | ---858.65K |
| Financing cash flow | |||||
| Cash flow from continuing financing activities | -51.24%918.56K | -90.86%1.88M | 314.61%20.61M | -32.92%4.97M | 7.41M |
| Net issuance payments of debt | -112.37%-337.56K | 4,817.09%2.73M | ---57.86K | ---- | ---- |
| Net common stock issuance | --1.57M | ---- | 308.75%21.16M | -30.14%5.18M | --7.41M |
| Interest paid (cash flow from financing activities) | -192.68%-191.65K | ---65.48K | ---- | ---21.74K | ---- |
| Net other financing activities | 84.06%-124.34K | -57.56%-779.85K | -167.76%-494.94K | ---184.85K | ---- |
| Cash from discontinued financing activities | |||||
| Financing cash flow | -51.24%918.56K | -90.86%1.88M | 314.61%20.61M | -32.92%4.97M | --7.41M |
| Net cash flow | |||||
| Beginning cash position | -61.91%4.85M | 630.02%12.72M | -60.56%1.74M | 8,332.96%4.42M | --52.4K |
| Current changes in cash | 59.33%-3.2M | -171.76%-7.88M | 510.30%10.98M | -161.28%-2.68M | --4.37M |
| Effect of exchange rate changes | -95.37%78 | 66.34%1.69K | --1.01K | ---- | ---- |
| End cash Position | -66.11%1.64M | -61.91%4.85M | 630.02%12.72M | -60.56%1.74M | --4.42M |
| Free cash from | 57.21%-4.13M | -2.10%-9.65M | -29.00%-9.45M | -140.82%-7.33M | ---3.04M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Analysis
Price Target
No Data
Heat List
AU
Overall
Symbol
Latest Price
% Chg
No Data